RJA
TMDI

Raymond James & Associates’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Raymond James & Associates’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-27,112
Closed -$17.9K – 4142
2022
Q4 		$17.9K Sell
27,112
-634
-2% -$334 ﹤0.01% 3804
2022
Q3 		$12K Sell
27,746
-5,000
-15% -$2.59K ﹤0.01% 3848
2022
Q2 		$17K Sell
32,746
-118
-0.4% -$58 ﹤0.01% 3888
2022
Q1 		$17K Sell
32,864
-13,390
-29% -$7.77K ﹤0.01% 4025
2021
Q4 		$29K Sell
46,254
-6,989
-13% -$7.88K ﹤0.01% 4001
2021
Q3 		$81K Buy
53,243
+2,000
+4% +$3.25K ﹤0.01% 3867
2021
Q2 		$88K Buy
51,243
+800
+2% +$1.38K ﹤0.01% 3858
2021
Q1 		$86K Buy
50,443
+26,238
+108% +$58.7K ﹤0.01% 3797
2020
Q4 		$41K Buy
24,205
+8,529
+54% +$8.47K ﹤0.01% 3642
2020
Q3 		$12K Buy
15,676
+100
+0.6% +$79 ﹤0.01% 3538
2020
Q2 		$13K Buy
+15,576
New +$7.98K ﹤0.01% 3471

Other funds holding TMDI

EL
Essex LLC Deer Park, Illinois $659M AUM 41.98% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
WA
Waterford Advisors Orchard Park, New York $315M AUM 15.21% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
DIS
Diversified Investment Strategies Baton Rouge, Louisiana $155M AUM 21.54% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BCWM
Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Raymond James & Associates's TMDI Position: Q1 2023 in Review

Raymond James & Associates sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2023, closing a stake of 27,112 shares — an estimated $17.9K sold.

Raymond James & Associates first reported a position in TMDI in Q2 2020 and held it in 11 quarters. The position peaked at $88K in Q2 2021. 12 funds tracked by Wall St. Rank hold TMDI as of Q1 2023.

  • Raymond James & Associates reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Raymond James & Associates sold 27,112 Titan Medical Inc. Ordinary Shares shares in Q1 2023, an estimated $17.9K.
  • Raymond James & Associates first reported a position in Titan Medical Inc. Ordinary Shares in Q2 2020 and held it in 11 quarters.
  • Raymond James & Associates's Titan Medical Inc. Ordinary Shares position peaked at $88K in Q2 2021.
  • 12 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2023.

Based on Raymond James & Associates's 13F filing for Q1 2023, filed 14 Apr 2023.